High Indoleamine 2,3-Dioxygenase Expression along with Low Bridging Integrator-1 Expression in Hepatocellular Carcinoma Patients.

Kashif Asghar,Iftikhar Ali Rana,Muhammad Abubakar,Kinza Hasham,Muhammad Tahseen,Sundus Bilal,Shafqat Mehmood,Asim Farooq,Kashif Siddique,Asif Loya

Asian Pacific journal of cancer prevention : APJCP（2023）

引用 0|浏览3

暂无评分

摘要

Our data showed that expression of IDO along with Bin1 expression could be investigated for clinical evaluation in HCC. IDO might be used as an immunotherapeutic target for HCC. Therefore, further studies in larger patient cohorts are warranted.

查看译文

关键词

hepatocellular carcinoma,high indoleamine

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要